APDN - アプライドDNAサイエンシス （Applied DNA Sciences Inc）

https://www.investing.com/news/assorted/applied-dna-sciences-files-a-75-million-mixed-securities-shelf-432SI-3094194

The following slide deck was published by Applied DNA Sciences, Inc.

Applied DNA Sciences, Inc. (NASDAQ:NASDAQ:APDN) Q2 2023 Results Earnings Conference Call May 12, 2023 4:30 PM ETCompany ParticipantsSanjay Hurry - Head of Investor RelationsBeth Jantzen -…

Applied DNA Sciences (NASDAQ: APDN ) reported its Q2 earnings results on Thursday, May 11, 2023 at 04:05 PM. Here''s what investors need to know about the announcement. Earnings Applied DNA Sciences reported in-line EPS of … Full story available on Benzinga.com

- linearDNA Gaining Momentum as a Differentiated DNA Template for mRNA Production, Company Identifies Early Development-Stage Acquisition Target to Potentially Expand Commercial Advantages -- Balan…

SEEL has seen its SMA50 which is now -16.02%. In looking the SMA 200 we see that the stock has seen a -17.33%. APDN has seen its SMA50 which is … The post This stocks will boost Up Your investment: Seelos Therapeutics, Inc. (NASDAQ:SEEL -2.54%), Applied DNA Sciences, Inc. (NASDAQ:APDN) appeared first on Stocks Equity .

Benzinga Pro data, Applied DNA Sciences (NASDAQ: APDN ) reported Q1 sales of $5.26 million. Earnings fell to a loss of $3.84 million, resulting in a 478.47% decrease from last quarter. Applied DNA Sciences collected $3.56 million in revenue during Q4, but reported earnings showed a $664 thousand loss. What Is ROCE? Return on Capital Employed is a measure of yearly pre-tax profit relative to capital employed by a business. Changes in earnings and sales indicate shifts in a company''s ROCE. A higher ROCE is generally representative of successful growth of a company and is a … Full story available on Benzinga.com

Applied DNA Sciences, Inc. (NASDAQ: APDN) (the “Company”), a leader in PCR-based DNA technologies, today announced the receipt of an up to $1.5 million award from New York State’s Empire State Development (ESD) agency. The award is provided by ESD under the Excelsior Jobs Program for qualifying net new job creation as refundable employee tax credits claimed over a benefit period of up to

Applied DNA Sciences, Inc. (NASDAQ:NASDAQ:APDN) Q1 2023 Earnings Conference Call February 9, 2023 4:30 PM ETCompany ParticipantsSanjay Hurry - Investor RelationsBeth Jantzen - Chief…

The following slide deck was published by Applied DNA Sciences, Inc.

STONY BROOK, N.Y.--(BUSINESS WIRE)---- $APDN #LinearDNA--Applied DNA Sciences, Inc. (NASDAQ: APDN), a leader in cell-free, enzymatic DNA production, today announced that CEO Dr. James A. Hayward is invited to present at the 2022 Virtual Growth Conference presented by Maxim Group LLC and hosted by M-Vest, on March 28th - 30th from 9:00 a.m. - 5:00 p.m. EDT. Dr. Hayward’s presentation will be available on-demand for the duration of the conference via the sign-up link: Sign up here to access the presentation During th

The shares of life sciences company, Applied DNA Sciences <> are rising on Wednesday amid reports that the U.S

Applied DNA Sciences, Inc. (NASDAQ: APDN ) a polymerase chain reaction based DNA manufacturer , closed its previously announced registered direct offering with an institutional investor of 1.5 million shares of common stock at a price of $2.80 per share for gross proceeds of approximately $4.2 million , before deducting the placement agent’s fees and other offering expenses payable by the company. In a concurrent private placement, Applied DNA also issued to the institutional investor in the offering unregistered … Full story available on Benzinga.com

Applied DNA Sciences (APDN) has dropped -12.80% pre-market after pricing its share offering.The company entered into a securities purchase agreement with an institutional investor for